Stay updated on Nivolumab After SIRT for HCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.

Latest updates to the Nivolumab After SIRT for HCC Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedSubstantive content on the study page is replaced by a 403 Forbidden error. This blocks access to the study's details and related information.SummaryDifference18%

- Check47 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, reflecting a new page version in the footer.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor platform update and does not alter the study details or user interactions on the page.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a software update to the page's release version.SummaryDifference0.1%

- Check104 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, reflecting a backend/template update. It represents a maintenance release rather than a change to the study details or public content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab After SIRT for HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.